Hodgkin Lymphoma (C81)

Name of the Condition

• Common Name: Hodgkin Lymphoma
• Medical Terms: Hodgkin's Disease, Hodgkin Lymphoma

Summary

Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed-Sternberg cells. It typically involves lymph nodes and can spread to other lymphoid tissues or organs. The disease is classified into subtypes based on cellular and structural features, with treatment outcomes varying by subtype and stage.

Causes

The exact cause of Hodgkin lymphoma is not fully understood, but it is thought to result from a combination of genetic predisposition and environmental factors. Viral infections, such as Epstein-Barr virus (EBV), have been associated with some cases, though not all.

Risk Factors

• Age: Most common in young adults (15-35) and older adults (over 55).
• Gender: Slightly more prevalent in males.
• Family History: Having a first-degree relative with lymphoma may increase risk.
• Immune System: Weakened immunity (e.g., from HIV/AIDS or immunosuppressive therapy) can elevate risk.
• Epstein-Barr Virus: Prior infection may contribute to development.

Symptoms

• Painless swelling of lymph nodes, often in the neck, armpits, or groin.
• Persistent fatigue or weakness.
• Unexplained fever or night sweats.
• Unintended weight loss.
• Itchy skin (pruritus).
• Cough or shortness of breath (if chest lymph nodes are involved).

Diagnosis

Diagnosis involves a physical examination to assess lymph node enlargement, followed by imaging tests (e.g., CT, PET, or MRI scans) to identify affected areas. A lymph node biopsy is essential to confirm the presence of Reed-Sternberg cells and determine the subtype. Blood tests may evaluate overall health and organ function.

Treatment Options

• Chemotherapy: The primary treatment, often using multi-drug regimens to target cancer cells.
• Radiation Therapy: Used for localized disease or as an adjunct to chemotherapy.
• Immunotherapy: May be considered for refractory or relapsed cases.
• Stem Cell Transplant: An option for advanced or resistant disease.

Prognosis and Follow-Up

Prognosis depends on the subtype, stage, and patient age. Early-stage disease has a high cure rate with standard treatments. Regular follow-up appointments, including imaging and blood tests, are necessary to monitor for recurrence or late effects of therapy.

Complications

• Recurrence of cancer after treatment.
• Secondary cancers (e.g., leukemia) from chemotherapy or radiation.
• Long-term fatigue or organ damage from treatment.
• Increased susceptibility to infections due to immune suppression.

Lifestyle & Prevention

• Maintain a balanced diet and regular exercise to support overall health.
• Avoid smoking and limit alcohol, as these may exacerbate treatment side effects.
• Practice good hygiene to reduce infection risk during immunosuppression.
• Stay up-to-date with vaccinations (as recommended by a healthcare provider).

When to Seek Professional Help

Seek immediate medical attention if you experience persistent lymph node swelling, unexplained weight loss, severe fatigue, or fever. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

When coding for Hodgkin lymphoma (C81), ensure documentation specifies the subtype (e.g., nodular sclerosis, mixed cellularity) if available, as this may impact treatment and prognosis. Verify that the site of involvement (e.g., lymph nodes, extranodal) is clearly documented to support accurate code assignment. Review clinical notes for details on staging, treatment response, or complications to ensure comprehensive coding.